[Review] WHO assessment of the preclinical antifungal pipeline: evaluating innovation and preparedness in the face of emerging fungal threats | ClinicLens
Life-threatening invasive and mucosal fungal infections are a major, increasingly complex global health problem. Among all population groups, individuals who are immunocompromised face the greatest risk of contracting such infections, and the size of these global populations is g
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.